Extensive cardiac FDG uptake in a patient with AL amyloidosis

J Nucl Cardiol. 2023 Aug;30(4):1497-1503. doi: 10.1007/s12350-023-03243-1. Epub 2023 Mar 17.

Abstract

Cardiac AL amyloidosis is a medical emergency causing rapid deterioration of cardiac function; however, it remains to be a diagnostic challenge especially when presenting with unusual symptoms and clinical findings. We present case of a 44-year-old patient with typical angina, persistently elevated troponin and normal epicardial coronary arteries. He was initially treated for myocarditis due to chest pain with troponin rise. However, CMR finding of subendocardial enhancement, increased native T1 values as well as extensive diffuse FDG uptake on PET-CT also suggested inflammatory cardiac conditions. Rapid decline in LV function and clinical deterioration led to further investigations including serum free light chains and bone marrow biopsy which confirmed systemic AL amyloidosis. Although the pathophysiology of unusual FDG PET-CT findings remains unknown, marked myocardial FDG uptake might have been caused by various features that were associated with AL amyloidosis including myocardial cell toxicity/inflammation or microvascular dysfunction. Awareness of these features specific to AL amyloidosis among physicians and description of associated cardiac FDG uptake findings has a potential to aid early diagnosis.

Keywords: Amyloid heart disease; PET; inflammation; microvascular dysfunction; multimodality.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amyloidosis* / complications
  • Amyloidosis* / diagnostic imaging
  • Fluorodeoxyglucose F18
  • Heart
  • Humans
  • Immunoglobulin Light-chain Amyloidosis* / complications
  • Immunoglobulin Light-chain Amyloidosis* / diagnostic imaging
  • Male
  • Positron Emission Tomography Computed Tomography

Substances

  • Fluorodeoxyglucose F18